Medtech Insight is part of the Business Intelligence Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

Biosdue secures over 50% of Snia:

This article was originally published in Clinica

Executive Summary

Italian financial company Biosdue, a wholly-owned subsidiary of holding company Bios, has announced that it holds 50.1% of biomedical and chemical group Snia, after launching a bid for full control in February (see Clinica No 984, p 15). Bios already owned a 28.3% majority stake in Snia. The group is expected to focus on its biomedical activities, according to comments made by Emilio Gnutti, head of Bios, in an interview with Italian daily Il Sole 24 Ore. Approximately half of Snia's revenues are generated through its medical technology division.

Advertisement

Topics

Advertisement
UsernamePublicRestriction

Register

MT066037

Ask The Analyst

Please Note: You can also Click below Link for Ask the Analyst
Ask The Analyst

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel